Alx Oncology Holdings (ALXO) Insider Trading
- $1,569,764.00
- $32,641,022.97
- April 16, 2024
- Jaume Pons
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 16, 2024 | Insider | 50,000 | $14.20 | Sell | $710,000.00 | |
April 4, 2024 | Insider | 20,000 | $11.15 | Sell | $223,000.00 | |
March 14, 2024 | CEO | 4,400 | $11.31 | Buy | $49,764.00 | |
Jan. 4, 2024 | CAO | 2,717 | $13.60 | Sell | $36,951.20 | |
July 6, 2023 | CAO | 7,345 | $6.52 | Sell | $47,889.40 | |
June 30, 2023 | CFO | 887 | $7.34 | Sell | $6,510.58 | |
June 30, 2023 | Insider | 1,605 | $7.34 | Sell | $11,780.70 | |
June 30, 2023 | CEO | 3,208 | $7.34 | Sell | $23,546.72 | |
June 30, 2023 | CAO | 466 | $7.34 | Sell | $3,420.44 | |
Dec. 13, 2021 | Director | 325,377 | $27.36 | Sell | $8,902,314.72 | |
Dec. 13, 2021 | Major Shareholder | 48,390 | $26.61 | Sell | $1,287,657.90 | |
Dec. 10, 2021 | Major Shareholder | 26,274 | $31.31 | Sell | $822,638.94 | |
Dec. 9, 2021 | Director | 76,905 | $32.03 | Sell | $2,463,267.15 | |
Dec. 8, 2021 | Major Shareholder | 42,458 | $33.25 | Sell | $1,411,728.50 | |
Nov. 22, 2021 | Insider | 14,884 | $36.77 | Sell | $547,284.68 | |
Oct. 19, 2021 | CEO | 16,700 | $54.29 | Sell | $906,643.00 | |
Oct. 18, 2021 | CFO | 7,229 | $55.44 | Sell | $400,775.76 | |
Oct. 11, 2021 | Insider | 7,387 | $60.97 | Sell | $450,385.39 | |
Sept. 20, 2021 | CEO | 16,700 | $74.38 | Sell | $1,242,146.00 | |
Sept. 16, 2021 | CFO | 1,426 | $80.43 | Sell | $114,693.18 | |
Sept. 10, 2021 | Insider | 7,387 | $77.66 | Sell | $573,674.42 | |
Aug. 23, 2021 | CFO | 60,000 | $74.15 | Sell | $4,449,000.00 | |
Aug. 19, 2021 | CEO | 16,700 | $61.28 | Sell | $1,023,376.00 | |
Aug. 17, 2021 | CFO | 10,000 | $66.23 | Sell | $662,300.00 | |
July 19, 2021 | CEO | 16,700 | $54.57 | Sell | $911,319.00 | |
July 12, 2021 | Insider | 7,387 | $54.90 | Sell | $405,546.30 | |
June 21, 2021 | CEO | 16,700 | $58.59 | Sell | $978,453.00 | |
May 19, 2021 | CEO | 16,700 | $55.71 | Sell | $930,357.00 | |
April 19, 2021 | CEO | 16,700 | $57.63 | Sell | $962,421.00 | |
April 12, 2021 | Insider | 7,387 | $59.43 | Sell | $439,009.41 | |
March 22, 2021 | CEO | 16,700 | $68.49 | Sell | $1,143,783.00 | |
March 10, 2021 | Insider | 7,387 | $74.34 | Sell | $549,149.58 | |
Dec. 14, 2020 | Director | 20,000 | $76.00 | Buy | $1,520,000.00 |
Insiders are both buying and selling Alx Oncology Holdings stock.
The insider traders at Alx Oncology Holdings are: Jaume Pons, Sophia Randolph, Lsv Associates, Llc, Peter S Garcia, Jason Lettmann, Shelly Pinto, Peter S. Garcia, and G. Walmsley Graham
The most active insider trader at Alx Oncology Holdings is Jaume Pons with 11 trades.
Jason Lettmann has sold the most Alx Oncology Holdings stock with a total value of $20,267,896.59.
G. Walmsley Graham has bought the most Alx Oncology Holdings stock with a total value of $3,040,000.00.
The most recent insider trade for Alx Oncology Holdings was on April 16, 2024.
The single biggest insider buy for Alx Oncology Holdings was from G. Walmsley Graham with a total value of $1,520,000.00 on Dec. 14, 2020.
The single biggest insider sell for Alx Oncology Holdings was from Jason Lettmann with a total value of $8,902,314.72 on Dec. 13, 2021.